Loading...

ReWalk Robotics

DB:2RW
Snowflake Description

Limited growth with imperfect balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
2RW
DB
$13M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The last earnings update was 13 days ago. More info.


Add to Portfolio Compare Print
  • ReWalk Robotics has significant price volatility in the past 3 months.
2RW Share Price and Events
7 Day Returns
4.2%
DB:2RW
2.6%
DE Medical Equipment
0.3%
DE Market
1 Year Returns
-88.8%
DB:2RW
13.4%
DE Medical Equipment
-11.6%
DE Market
2RW Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
ReWalk Robotics (2RW) 4.2% -17.9% -64% -88.8% -98.7% -
DE Medical Equipment 2.6% 2.6% 5.6% 13.4% 109.3% 237.2%
DE Market 0.3% -3.8% 2.5% -11.6% 10.1% 7.9%
1 Year Return vs Industry and Market
  • 2RW underperformed the Medical Equipment industry which returned 13.4% over the past year.
  • 2RW underperformed the Market in Germany which returned -11.6% over the past year.
Price Volatility
2RW
Industry
5yr Volatility vs Market

2RW Value

 Is ReWalk Robotics undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for ReWalk Robotics. This is due to cash flow or dividend data being unavailable. The share price is €2.502.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for ReWalk Robotics's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are ReWalk Robotics's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:2RW PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $-9.80
NasdaqCM:RWLK Share Price ** NasdaqCM (2019-05-21) in USD $2.94
Germany Medical Equipment Industry PE Ratio Median Figure of 9 Publicly-Listed Medical Equipment Companies 35.68x
Germany Market PE Ratio Median Figure of 423 Publicly-Listed Companies 20.29x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of ReWalk Robotics.

DB:2RW PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:RWLK Share Price ÷ EPS (both in USD)

= 2.94 ÷ -9.80

-0.3x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • ReWalk Robotics is loss making, we can't compare its value to the DE Medical Equipment industry average.
  • ReWalk Robotics is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does ReWalk Robotics's expected growth come at a high price?
Raw Data
DB:2RW PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.3x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
20.8%per year
Germany Medical Equipment Industry PEG Ratio Median Figure of 6 Publicly-Listed Medical Equipment Companies 3.02x
Germany Market PEG Ratio Median Figure of 272 Publicly-Listed Companies 1.5x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for ReWalk Robotics, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on ReWalk Robotics's assets?
Raw Data
DB:2RW PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $0.56
NasdaqCM:RWLK Share Price * NasdaqCM (2019-05-21) in USD $2.94
Germany Medical Equipment Industry PB Ratio Median Figure of 13 Publicly-Listed Medical Equipment Companies 4.16x
Germany Market PB Ratio Median Figure of 576 Publicly-Listed Companies 1.79x
DB:2RW PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:RWLK Share Price ÷ Book Value per Share (both in USD)

= 2.94 ÷ 0.56

5.29x

* Primary Listing of ReWalk Robotics.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • ReWalk Robotics is overvalued based on assets compared to the DE Medical Equipment industry average.
X
Value checks
We assess ReWalk Robotics's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. ReWalk Robotics has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

2RW Future Performance

 How is ReWalk Robotics expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
20.8%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is ReWalk Robotics expected to grow at an attractive rate?
  • Unable to compare ReWalk Robotics's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare ReWalk Robotics's earnings growth to the Germany market average as it is expected to be loss making during the next 1-3 years.
  • ReWalk Robotics's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:2RW Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:2RW Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 20.8%
DB:2RW Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 22.9%
Germany Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 12.8%
Germany Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
Germany Market Earnings Growth Rate Market Cap Weighted Average 13%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:2RW Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:2RW Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 19 -6 1
2022-12-31 15 -9 1
2021-12-31 12 -11 1
2020-12-31 10 -13 1
2019-12-31 7 -15 1
DB:2RW Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 7 -14 -19
2018-12-31 7 -15 -22
2018-09-30 6 -18 -23
2018-06-30 7 -20 -24
2018-03-31 7 -21 -25
2017-12-31 8 -22 -25
2017-09-30 8 -24 -27
2017-06-30 7 -25 -29
2017-03-31 6 -27 -32
2016-12-31 6 -27 -33
2016-09-30 6 -27 -31
2016-06-30 5 -27 -30

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • ReWalk Robotics is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • ReWalk Robotics's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:2RW Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from ReWalk Robotics Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:2RW Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31 -0.38 -0.38 -0.38 1.00
2022-12-31 -0.53 -0.53 -0.53 1.00
2021-12-31 -0.79 -0.79 -0.79 1.00
2020-12-31 -1.12 -1.12 -1.12 1.00
2019-12-31 -2.41 -2.41 -2.41 1.00
DB:2RW Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 -9.80
2018-12-31 -14.72
2018-09-30 -18.43
2018-06-30 -21.94
2018-03-31 -26.09
2017-12-31 -30.57
2017-09-30 -38.37
2017-06-30 -47.31
2017-03-31 -56.26
2016-12-31 -61.66
2016-09-30 -63.36
2016-06-30 -61.04

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if ReWalk Robotics will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess ReWalk Robotics's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
ReWalk Robotics has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

2RW Past Performance

  How has ReWalk Robotics performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare ReWalk Robotics's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • ReWalk Robotics does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare ReWalk Robotics's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare ReWalk Robotics's 1-year growth to the DE Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
ReWalk Robotics's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from ReWalk Robotics Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:2RW Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 6.55 -19.35 13.40 6.61
2018-12-31 6.55 -21.68 14.69 7.35
2018-09-30 6.48 -22.82 16.42 7.25
2018-06-30 6.60 -24.13 17.57 7.28
2018-03-31 6.83 -24.64 18.15 6.76
2017-12-31 7.75 -24.72 19.05 6.04
2017-09-30 7.83 -27.10 20.05 6.72
2017-06-30 7.50 -29.17 21.33 5.97
2017-03-31 6.31 -31.98 22.21 7.66
2016-12-31 5.87 -32.50 22.15 7.93
2016-09-30 5.61 -31.47 22.39 7.32
2016-06-30 5.38 -29.94 21.79 7.72
2016-03-31 5.17 -26.63 20.65 6.10
2015-12-31 3.75 -25.42 19.45 5.94
2015-09-30 3.88 -23.40 17.10 5.50
2015-06-30 4.25 -24.28 14.94 9.39
2015-03-31 4.14 -23.87 13.00 9.02
2014-12-31 3.95 -23.90 10.74 8.56
2014-09-30 2.87 -20.88 9.00 8.14
2014-06-30 1.74 -18.90 7.68 3.56
2014-03-31 1.48 -16.98 6.30 3.15
2013-12-31 1.59 -13.84 5.85 2.46
2012-12-31 0.97 -7.66 3.99 1.76

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if ReWalk Robotics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if ReWalk Robotics has efficiently used its assets last year compared to the DE Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if ReWalk Robotics improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess ReWalk Robotics's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
ReWalk Robotics has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

2RW Health

 How is ReWalk Robotics's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up ReWalk Robotics's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • ReWalk Robotics is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • ReWalk Robotics's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of ReWalk Robotics's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from ReWalk Robotics Company Filings, last reported 1 month ago.

DB:2RW Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 2.06 10.43 8.86
2018-12-31 1.95 8.69 9.55
2018-09-30 -5.22 12.42 5.23
2018-06-30 -1.26 13.08 9.09
2018-03-31 -1.50 14.24 8.82
2017-12-31 3.71 15.35 14.57
2017-09-30 1.34 15.67 12.93
2017-06-30 3.40 15.98 16.26
2017-03-31 3.34 16.88 17.13
2016-12-31 8.26 18.01 23.68
2016-09-30 4.70 10.48 12.40
2016-06-30 8.05 10.31 15.69
2016-03-31 15.91 10.14 21.81
2015-12-31 20.92 0.00 17.91
2015-09-30 27.74 0.00 25.14
2015-06-30 33.62 0.00 31.17
2015-03-31 38.80 0.00 36.96
2014-12-31 43.85 0.00 43.55
2014-09-30 49.30 0.00 47.68
2014-06-30 2.36 0.00 0.96
2014-03-31 6.07 0.00 5.36
2013-12-31 8.97 0.00 8.91
2012-12-31 -0.10 0.68 0.77
  • ReWalk Robotics's level of debt (507.5%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (0% vs 507.5% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • ReWalk Robotics has less than a year of cash runway based on current free cash flow.
  • ReWalk Robotics has less than a year of cash runway if free cash flow continues to reduce at historical rates of -20.4% each year.
X
Financial health checks
We assess ReWalk Robotics's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. ReWalk Robotics has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

2RW Dividends

 What is ReWalk Robotics's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from ReWalk Robotics dividends.
If you bought €2,000 of ReWalk Robotics shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate ReWalk Robotics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate ReWalk Robotics's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:2RW Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Germany Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 1.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3.2%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:2RW Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as ReWalk Robotics has not reported any payouts.
  • Unable to verify if ReWalk Robotics's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of ReWalk Robotics's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as ReWalk Robotics has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess ReWalk Robotics's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can ReWalk Robotics afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. ReWalk Robotics has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

2RW Management

 What is the CEO of ReWalk Robotics's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Larry Jasinski
COMPENSATION $769,673
AGE 61
TENURE AS CEO 7.3 years
CEO Bio

Mr. Lawrence J. Jasinski, also known as Larry, BS, MBA has been the Chief Executive Officer at ReWalk Robotics Ltd. (formerly Argo Medical Technologies) since February 2012. From 2005 to 2012, Mr. Jasinski served as President and Chief Executive Officer at Soteira, Inc., a company engaged in development and commercialization of products used to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. He served as President and Chief Executive Officer at Cortek Inc. from 2001 to November 2005. From 1985 to 2001, Mr. Jasinski worked at Boston Scientific Corporation and served as its Vice President of Global Marketing, BSC Vascular, from 1998 to 2000. He serves as a Director at LeMaitre Vascular, Inc. since 2003 and ReWalk Robotics Ltd. since February 2012. He served as a Director of Cortek, Inc. Mr. Jasinski is also a member of the Board of Directors for Massachusetts Bay Lines, since 2015. Mr. Jasinski received his BS in Marketing from Providence College and his MBA from the University of Bridgeport.

CEO Compensation
  • Larry's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Larry's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the ReWalk Robotics management team in years:

1.9
Average Tenure
61
Average Age
  • The average tenure for the ReWalk Robotics management team is less than 2 years, this suggests a new team.
Management Team

Larry Jasinski

TITLE
CEO & Director
COMPENSATION
$770K
AGE
61
TENURE
7.3 yrs

Ori Gon

TITLE
Chief Financial Officer
COMPENSATION
$462K
AGE
38
TENURE
1.3 yrs

Miri Pariente

TITLE
Vice President of QA & Operations
AGE
41
TENURE
2.3 yrs

Loren Wass

TITLE
Vice President of Sales & Reimbursement
TENURE
2.2 yrs

Andy Dolan

TITLE
Vice President of Marketing
TENURE
1.2 yrs

Judy Kula

TITLE
Vice President of Customer Service
TENURE
1.2 yrs

Ami Kraft

TITLE
Executive Advisor to the CEO
COMPENSATION
$310K
AGE
75
TENURE
1.6 yrs

John Hamilton

TITLE
Consultant
COMPENSATION
$386K
AGE
64
TENURE
2.3 yrs
Board of Directors Tenure

Average tenure and age of the ReWalk Robotics board of directors in years:

5.8
Average Tenure
59.5
Average Age
  • The tenure for the ReWalk Robotics board of directors is about average.
Board of Directors

Jeff Dykan

TITLE
Chairman of the Board
COMPENSATION
$25K
AGE
59
TENURE
10.3 yrs

Larry Jasinski

TITLE
CEO & Director
COMPENSATION
$770K
AGE
61
TENURE
7.3 yrs

Bill Poduska

TITLE
Independent Director
COMPENSATION
$70K
AGE
80
TENURE
4.7 yrs

Yohanan Engelhardt

TITLE
Director
COMPENSATION
$52K
AGE
60
TENURE
1 yrs

Wayne Weisman

TITLE
Independent Director
COMPENSATION
$25K
AGE
62
TENURE
10.3 yrs

Arik Dan

TITLE
Director
COMPENSATION
$25K
AGE
59
TENURE
6.3 yrs

Yasushi Ichiki

TITLE
Director
COMPENSATION
$25K
AGE
50
TENURE
5.3 yrs

Pete Wehrly

TITLE
Independent Director
COMPENSATION
$61K
AGE
59
TENURE
3.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
29. Nov 18 Sell Lawrence Jasinski Individual 28. Nov 18 28. Nov 18 -16 €5.32 €-83
27. Aug 18 Sell Lawrence Jasinski Individual 24. Aug 18 24. Aug 18 -15 €22.16 €-339
29. Jun 18 Sell Lawrence Jasinski Individual 27. Jun 18 27. Jun 18 -63 €21.35 €-1,353
31. May 18 Sell Lawrence Jasinski Individual 24. May 18 24. May 18 -17 €22.39 €-379
X
Management checks
We assess ReWalk Robotics's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. ReWalk Robotics has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

2RW News

Simply Wall St News

2RW Company Info

Description

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke. ReWalk Robotics Ltd. markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokne'am Illit, Israel.

Details
Name: ReWalk Robotics Ltd.
2RW
Exchange: DB
Founded: 2001
$11,896,369
4,517,566
Website: http://www.rewalk.com
Address: ReWalk Robotics Ltd.
3 Hatnufa Street,
6th Floor,
Yokne'am Illit,
2069203,
Israel
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM RWLK Ordinary Shares Nasdaq Capital Market US USD 12. Sep 2014
DB 2RW Ordinary Shares Deutsche Boerse AG DE EUR 12. Sep 2014
Number of employees
Current staff
Staff numbers
58
ReWalk Robotics employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/21 22:20
End of day share price update: 2019/05/21 00:00
Last estimates confirmation: 2019/05/08
Last earnings filing: 2019/05/08
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.